| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 67, 919-926, Copyright © 1998 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
BJ Geerling, A Badart-Smook, RW Stockbrugger and RJ Brummer
Department of Gastroenterology, University Hospital Maastricht, The Netherlands. bgee@sint.azm.nl
Malnutrition is observed frequently and is an important complication in patients with Crohn disease (CD). The pathophysiology of malnutrition in this disorder is complex. To obtain a comprehensive picture of nutritional status in patients with long-standing CD that was clinically in remission, we assessed four measures of nutritional status in 32 patients (18 women and 14 men) and 32 matched healthy control subjects: 1) body composition, 2) dietary intake, 3) biochemical indexes of nutrition, and 4) and muscle strength (as a functional index). Mean daily intakes of fiber and phosphorus were significantly lower in CD patients than in control subjects. Serum concentrations of several nutrients (beta-carotene, vitamin C, vitamin E, selenium, and zinc) and activity of the enzyme glutathione peroxidase were also significantly lower in CD patients, as were antioxidant status and serum concentrations of magnesium and vitamin D. Percentage body fat and hamstring muscle strength were significantly lower in male CD patients than in control subjects, whereas muscle strength of the quadriceps was preserved. In conclusion, this study showed a variety of nutritional and functional deficiencies in patients with long-standing CD in remission, especially in male patients with a high lifetime prednisone dose. A comprehensive nutritional assessment seems superior to the assessment of a single dimension of nutritional status.
This article has been cited by other articles:
|
|
 |
|
  D. Wiese, B. Lashner, and D. Seidner Measurement of Nutrition Status in Crohn's Disease Patients Receiving Infliximab Therapy Nutr Clin Pract, October 1, 2008; 23(5): 551 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Wiese, R. Rivera, and D. L. Seidner Is There a Role for Bowel Rest in Nutrition Management of Crohn's Disease? Nutr Clin Pract, June 1, 2008; 23(3): 309 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Vagianos, S. Bector, J. McConnell, and C. N. Bernstein Nutrition Assessment of Patients With Inflammatory Bowel Disease JPEN J Parenter Enteral Nutr, July 1, 2007; 31(4): 311 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Troost, R.-J. M. Brummer, G. R. M. M. Haenen, A. Bast, R. I. van Haaften, C. T. Evelo, and W. H. M. Saris Gene expression in human small intestinal mucosa in vivo is mediated by iron-induced oxidative stress Physiol Genomics, April 11, 2006; 25(2): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Troost, R.-J. M. Brummer, G. R. M. M. Haenen, A. Bast, R. I. van Haaften, C. T. Evelo, and W. H. M. Saris Gene expression in human small intestinal mucosa in vivo is mediated by iron-induced oxidative stress Physiol Genomics, April 11, 2006; 25(2): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Burnham, J. Shults, E. Semeao, B. J Foster, B. S Zemel, V. A Stallings, and M. B Leonard Body-composition alterations consistent with cachexia in children and young adults with Crohn disease Am. J. Clinical Nutrition, August 1, 2005; 82(2): 413 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Dray and P. Marteau The Use of Enteral Nutrition in the Management of Crohn's Disease in Adults JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4_suppl): S166 - S172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T Cantorna, Y. Zhu, M. Froicu, and A. Wittke Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1717S - 1720S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Gasche, M C E Lomer, I Cavill, and G Weiss Iron, anaemia, and inflammatory bowel diseases Gut, August 1, 2004; 53(8): 1190 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Oz, M. Ray, T. S. Chen, and C. J. McClain Efficacy of a Transforming Growth Factor {beta}2 Containing Nutritional Support Formula in a Murine Model of Inflammatory Bowel Disease J. Am. Coll. Nutr., June 1, 2004; 23(3): 220 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Troost, W. H. M. Saris, G. R. M. M. Haenen, A. Bast, and R.-J. M. Brummer New method to study oxidative damage and antioxidants in the human small bowel: effects of iron application Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G354 - G359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Mackenzie, M. R. Warren, and L. J. Wykes Colitis Increases Albumin Synthesis at the Expense of Muscle Protein Synthesis in Macronutrient-Restricted Piglets J. Nutr., June 1, 2003; 133(6): 1875 - 1881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Briet, C. Twomey, and K. N Jeejeebhoy Effect of malnutrition and short-term refeeding on peripheral blood mononuclear cell mitochondrial complex I activity in humans Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1304 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hontecillas, M. J. Wannemeulher, D. R. Zimmerman, D. L. Hutto, J. H. Wilson, D. U. Ahn, and J. Bassaganya-Riera Nutritional Regulation of Porcine Bacterial-Induced Colitis by Conjugated Linoleic Acid J. Nutr., July 1, 2002; 132(7): 2019 - 2027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Jeejeebhoy Clinical nutrition: 6. Management of nutritional problems of patients with Crohn's disease Can. Med. Assoc. J., April 1, 2002; 166(7): 913 - 918. [Full Text] [PDF]
|
|
|
|
|
|
B. E Wendland, E. Aghdassi, C. Tam, J. Carrrier, A H. Steinhart, S. L Wolman, D. Baron, and J. P Allard Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease Am. J. Clinical Nutrition, August 1, 2001; 74(2): 259 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E J Schoon, M C A Muller, C Vermeer, L J Schurgers, R-J M Brummer, and R W Stockbrugger Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? Gut, April 1, 2001; 48(4): 473 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Cantorna, C. Munsick, C. Bemiss, and B. D. Mahon 1,25-Dihydroxycholecalciferol Prevents and Ameliorates Symptoms of Experimental Murine Inflammatory Bowel Disease J. Nutr., November 1, 2000; 130(11): 2648 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Wilmore Nutrition and Metabolic Support in the 21st Century JPEN J Parenter Enteral Nutr, January 1, 2000; 24(1): 1 - 4. [Abstract] [PDF]
|
|
|
|
|
|
D. W. Wilmore Impediments to the Successful Use of Anabolic Agents in Clinical Care JPEN J Parenter Enteral Nutr, November 1, 1999; 23(6_suppl): S210 - S213. [Abstract] [PDF]
|
|
|
|
|
|
D. W. Wilmore Growth Factors and Nutrients in the Short Bowel Syndrome JPEN J Parenter Enteral Nutr, September 1, 1999; 23(5_suppl): S117 - S120. [Abstract] [PDF]
|
|
|
|
|
|
E. Capristo, G. Addolorato, G. Mingrone, A. V Greco, G. Gasbarrini, B. J Geerling, and R.-J. M Brummer Nutritional status and energy metabolism in Crohn disease Am. J. Clinical Nutrition, February 1, 1999; 69(2): 339 - 340. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
